NCT01985581View on ClinicalTrials.gov

Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Guanfacine extended release

DRUG

Placebo

DRUG

Stimulant therapy

patient will continue to take stable dosage of usual stimulant therapy (Ritalin, Ritalin SR, Biphentin, Concerta, Vyvanse, Adderall or Dexedrine)

Trial Locations (1)

K2G1W2

JPM van Stralen Medicine Professional Corporation, Ottawa

All Listed Sponsors
lead

JPM van Stralen Medicine Professional

OTHER

NCT01985581 - Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD | Biotech Hunter | Biotech Hunter